Skip to main content
Have a personal or library account? Click to login
Sumatriptan Nasal Spray for Acute Migraine Cover

Sumatriptan Nasal Spray for Acute Migraine

Open Access
|Dec 1997

Abstract

The efficacy and side effects of intranasal sumatriptan (20 mg, 10 mg) or placebo in the treatment of a single migraine attack were evaluated in two randomized, double-blind, multicenter studies of 409 and 436 adult patients, funded by Glaxo Wellcome.
Language: English
Page range: 95 - 95
Published on: Dec 1, 1997
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.